Multiplex Assay Kit for Glial Fibrillary Acidic Protein (GFAP) ,etc. by FLIA (Flow Luminescence Immunoassay)

Intermediate Filament Protein

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Glial Fibrillary Acidic Protein (GFAP) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Glial Fibrillary Acidic Protein (GFAP) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Glial Fibrillary Acidic Protein (GFAP) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Glial Fibrillary Acidic Protein (GFAP) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 93-101 97
EDTA plasma(n=5) 86-101 94
heparin plasma(n=5) 95-103 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Glial Fibrillary Acidic Protein (GFAP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Glial Fibrillary Acidic Protein (GFAP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Glial Fibrillary Acidic Protein (GFAP) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-96% 82-92% 85-92% 95-102%
EDTA plasma(n=5) 79-101% 78-94% 82-89% 88-98%
heparin plasma(n=5) 95-104% 98-105% 79-101% 93-102%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:GFAP) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Occupational Health Effects of Exposure to 1-Bromopropane on Astrocytes and Oligodendrocytes in Rat Brain Pubmed: 23183024
Morfovirtual 2014 EFECTO PROTECTOR DEL TRATAMIENTO CON NEUROEPO SOBRE LA GLIA DE LA CORTEZA CEREBRAL EN RATONES TRANSGéNICOS CON LA ENFERMEDAD DE ALZHEIMER. Sld:Source
Annals of Anatomy Effect of memantine, a NMDA receptor blocker, on ethambutol-induced retinal injury PubMed: 26704355
Mediators of Inflammation IL-4 Inhibits IL-1β-Induced Depressive-Like Behavior and Central Neurotransmitter Alterations PubMed: 26417153
Neurochem Res Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat PubMed: 26700436
Cell Mol Neurobiol Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease PubMed: 26119304
Sleep and Biological Rhythms Relationship of orexin (hypocretin) system and astrocyte activation in Parkinson&#039;s disease with hypersomnolence Doi: 10.1111
Cellular and Molecular Neurobiology Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease Pubmed:26119304
Ann Anat Effect of memantine: A NMDA receptor blocker, on ethambutol-induced retinal injury Pubmed:26704355
United States Patent Application ESTROGENIC COMPONENTS FOR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS y2016:0101116.html
Clinical Research Human plasma glial fibrillary acidic protein and heat shock protein 27 concentrations in acute moderate-intensity aerobic exercise with different duration a825e1e27b0221df9a627769c0f614432e92.pdf
Medical Journal of Indonesia Comparison of GFAP and HSP27 concentrations in acute moderate-intensity aerobic exercise of different duration 2031884
Peptides. Carnosine ameliorates cognitive deficits in streptozotocin-induced diabetic rats: Possible involved mechanisms. pubmed:27777064
european journal of pharmacology Garlic active constituent s-allyl cysteine protects against lipopolysaccharide-induced cognitive deficits in the rat: Possible involved mechanisms. pubmed:27915041
european journal of pharmacology Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling. pubmed:28284752
biomedicine & pharmacotherapy Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat. pubmed:28199883
J Endocrinol.  Estrogen receptors and estetrol-dependent neuroprotective actions: a pilot study. pubmed:27799463
IOS Press Content Library An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's … articles:journal-of-alzheimers-disease
Tierärztliche Hochschule Hannover Evaluierung von Biomarkern im Liquor cerebrospinalis bei paraplegischen Hunden mit Rückenmarksverletzung :
Nigerian Journal of Clinical Practice Utilization of Glial Fibrillary Acidic Protein and Galectin-3 in the Diagnosis of Cerebral Infarction Patients with Normal Cranial Tomography pubmed:28406123
Cytokine Soy isoflavone genistein attenuates lipopolysaccharide-induced cognitive impairments in the rat via exerting anti-oxidative and anti-inflammatory effects pubmed:29102164
Biomedicine & pharmacotherapy Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms pubmed:28061403
Experimental gerontology The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling. pubmed:29107062
Pesticide Biochemistry and Physiology Acrolein-mediated neurotoxicity in growing Wistar male rats Pubmed:30033014
Journal of Perinatal Medicine Mechanisms of death in structurally normal stillbirths Pubmed: 30231013
Metabolic Brain Disease Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms Pubmed: 30456649
Metabolic Brain Disease Trigonelline protects hippocampus against intracerebral Aβ (1–40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms Pubmed: 30421246
博士论文 INSTITUTO DE CIENCIAS BÁSICAS Y PRECLÍNICAS “VICTORIA DE GIRÓN” DEPARTAMENTO DE HISTOLOGÍA
Medicina The Administration of the New Pyrimidine Derivative—4-{2-[2-(3, 4-Dimethoxyphenyl)-Vinyl]-6-Ethyl-4-Oxo-5-Phenyl-4H-Pyrimidine-1-Il} Benzsulfamide Restores the …
Open Access Macedonian Journal of Medical Sciences Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy Pubmed: 32165929
NEUROPSYCHOBIOLOGY Diosgenin Attenuates Cognitive Impairment in Streptozotocin-Induced Diabetic Rats: Underlying Mechanisms Pubmed: 32526752
JAMA Surgery Intraoperative dexmedetomidine for prevention of postoperative delirium in elderly patients with mild cognitive impairment Pubmed: 28593326
Acta Histochemica Quercetin mitigates monosodium glutamate-induced excitotoxicity of the spinal cord motoneurons in aged rats via p38 MAPK inhibition Pubmed: 32622428
stanbul Med J The Predictive Role of Neurobiochemical Markers in Multiple Sclerosis.
Basic and Clinical Neuroscience Paeonol Protects Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease 33995926
pharmacology online PHARMACOLOGICAL SCREENING OF A POTENTIALLY EFFECTIVE COMPOUND FOR THE TREATMENT OF CHRONIC TRAUMATIC ENCEPHALOPATHY?¡­
Neuropeptides The bee venom active compound melittin protects against bicuculline-induced seizures and hippocampal astrocyte activation in rats 34808488
Neural Plast P2Y2 Receptor Mediated Neuronal Regeneration and Angiogenesis to Affect Functional Recovery in Rats with Spinal Cord Injury Pubmed:35154311
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPA068Mu03 Recombinant Glial Fibrillary Acidic Protein (GFAP) Positive Control; Immunogen; SDS-PAGE; WB.
RPA068Mu02 Recombinant Glial Fibrillary Acidic Protein (GFAP) Positive Control; Immunogen; SDS-PAGE; WB.
RPA068Mu01 Recombinant Glial Fibrillary Acidic Protein (GFAP) Positive Control; Immunogen; SDS-PAGE; WB.
RPA068Mu04 Recombinant Glial Fibrillary Acidic Protein (GFAP) Positive Control; Immunogen; SDS-PAGE; WB.
PAA068Mu03 Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
PAA068Mu02 Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
PAA068Mu01 Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
PAA068Mu04 Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Mu22 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Mu23 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Mu21 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Mu24 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Mu25 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Mu27 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Mu28 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Mu29 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
SEA068Mu ELISA Kit for Glial Fibrillary Acidic Protein (GFAP) Enzyme-linked immunosorbent assay for Antigen Detection.
MEA068Mu Mini Samples ELISA Kit for Glial Fibrillary Acidic Protein (GFAP) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA068Mu Multiplex Assay Kit for Glial Fibrillary Acidic Protein (GFAP) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA068Mu01 ELISA Kit DIY Materials for Glial Fibrillary Acidic Protein (GFAP) Main materials for "Do It (ELISA Kit) Yourself".